Xiaowu Xu

2.4k total citations · 1 hit paper
82 papers, 1.7k citations indexed

About

Xiaowu Xu is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiaowu Xu has authored 82 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 36 papers in Molecular Biology and 31 papers in Epidemiology. Recurrent topics in Xiaowu Xu's work include Pancreatic and Hepatic Oncology Research (29 papers), Neuroendocrine Tumor Research Advances (27 papers) and Lung Cancer Research Studies (19 papers). Xiaowu Xu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (29 papers), Neuroendocrine Tumor Research Advances (27 papers) and Lung Cancer Research Studies (19 papers). Xiaowu Xu collaborates with scholars based in China, United States and Australia. Xiaowu Xu's co-authors include Yi Qin, Xianjun Yu, Shunrong Ji, Qifeng Zhuo, Ye Zeng, Wensheng Liu, Qiangsheng Hu, Guixiong Fan, Wenyan Xu and Mengqi Liu and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Xiaowu Xu

78 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer

2023 107 citations Ye Zeng, Zheng Li et al. Cell Proliferation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaowu Xu China	23	1.0k	629	531	393	226	82	1.7k
Paola Paterini Italy	16	659 0.7×	467 0.7×	673 1.3×	237 0.6×	163 0.7×	28	1.5k
Shumei Yan China	22	619 0.6×	365 0.6×	458 0.9×	312 0.8×	84 0.4×	58	1.3k
Wenfeng Cao China	22	947 0.9×	456 0.7×	396 0.7×	225 0.6×	114 0.5×	59	1.6k
Long Huang China	25	1.2k 1.1×	902 1.4×	296 0.6×	185 0.5×	170 0.8×	72	1.7k
Weibin Wang China	21	758 0.7×	575 0.9×	502 0.9×	182 0.5×	230 1.0×	86	1.5k
Jing Huang China	23	934 0.9×	634 1.0×	412 0.8×	159 0.4×	100 0.4×	81	1.6k
Chaoyun Pan China	19	1.0k 1.0×	668 1.1×	272 0.5×	223 0.6×	184 0.8×	29	1.5k
Edward L. LaGory United States	18	927 0.9×	718 1.1×	312 0.6×	256 0.7×	99 0.4×	25	1.5k
Rafael Malagoli Rocha Brazil	18	1.5k 1.5×	1.0k 1.6×	639 1.2×	244 0.6×	161 0.7×	49	2.2k
Timothy G. Pestell United States	13	990 1.0×	481 0.8×	663 1.2×	162 0.4×	297 1.3×	17	1.7k

Countries citing papers authored by Xiaowu Xu

Since Specialization

Citations

This map shows the geographic impact of Xiaowu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowu Xu more than expected).

Fields of papers citing papers by Xiaowu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowu Xu. The network helps show where Xiaowu Xu may publish in the future.

Co-authorship network of co-authors of Xiaowu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowu Xu. A scholar is included among the top collaborators of Xiaowu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowu Xu. Xiaowu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Borui, Ting Wang, Haifeng Hu, et al.. (2025). Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. Acta Pharmacologica Sinica. 46(6). 1742–1756. 4 indexed citations

Xie, Changqing, Ting Wang, Yan Wang, et al.. (2025). Liquid–Liquid Phase Separation in Major Hallmarks of Cancer. Cell Proliferation. 59(2). e70122–e70122. 1 indexed citations

Zhao, Faming, Xiaowu Xu, Yi Qin, et al.. (2025). Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression. Cancer Research. 85(15). 2805–2819.

Zhuo, Qifeng, Borui Li, Mengqi Liu, et al.. (2024). Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective cohort study. World Journal of Surgical Oncology. 22(1). 1–1. 5 indexed citations

Jia, Yuming, Ye Zeng, Xin Wang, et al.. (2024). <italic>NCOA6</italic> knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine. Acta Biochimica et Biophysica Sinica. 57(8). 1260–1269. 2 indexed citations

Wang, Jingyi, Xiaohong Wang, Chenjie Zhou, et al.. (2024). YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. Cancer Letters. 602. 217197–217197. 3 indexed citations

Fan, Guixiong, Qin Dang, Shunrong Ji, et al.. (2024). Transcription factor EB reprograms branched‐chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1. Cell Proliferation. 57(11). e13694–e13694. 7 indexed citations

Zeng, Ye, Qiang Li, Wuhu Zhang, et al.. (2024). The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Cancer Letters. 588. 216769–216769. 9 indexed citations

Jia, Yuming, et al.. (2023). Pyroptosis Provides New Strategies for the Treatment of Cancer. Journal of Cancer. 14(1). 140–151. 49 indexed citations

10.

Li, Zheng, Haidi Chen, Borui Li, et al.. (2023). Holistic anti-tumor resistance mechanism of YBX1 and its potential as a chemoresistance target in pancreatic ductal adenocarcinoma. 2(1). 2 indexed citations

11.

Wang, Ting, Yi Qin, Ye Zeng, et al.. (2023). A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. Acta Pharmacologica Sinica. 44(8). 1536–1548. 12 indexed citations

12.

Li, Borui, et al.. (2023). Reconsidering the role of prophylactic pancreaticojejunostomy in pancreatic enucleation: balancing the benefits and risks. ANZ Journal of Surgery. 94(3). 380–386. 2 indexed citations

13.

Zhuo, Qifeng, Heli Gao, Yi Qin, et al.. (2023). MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression. Cancer Research. 83(13). 2226–2247. 20 indexed citations

14.

Zeng, Ye, Zheng Li, Guixiong Fan, et al.. (2023). Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Proliferation. 56(10). e13478–e13478. 107 indexed citations breakdown →

15.

Xu, Xiaowu, Ye Zeng, Xin Lou, et al.. (2022). Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors. Pancreas. 51(10). 1404–1410. 3 indexed citations

16.

Qin, Yi, et al.. (2021). Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell Proliferation. 55(1). e13167–e13167. 63 indexed citations

17.

Hu, Qiangsheng, Yi Qin, Shunrong Ji, et al.. (2021). MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer Research. 81(19). 4964–4980. 31 indexed citations

18.

Liu, Mengqi, Yi Qin, Qiangsheng Hu, et al.. (2020). SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. Cancer Letters. 499. 265–278. 22 indexed citations

19.

Sun, Qiqing, Yiyin Zhang, Mengqi Liu, et al.. (2019). Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis. Cancer Cell International. 19(1). 309–309. 20 indexed citations

20.

Xu, Xiaowu, et al.. (2012). P2Y12 protects platelets from apoptosis via PI3k‐dependent Bak/Bax inactivation. Journal of Thrombosis and Haemostasis. 11(1). 149–160. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact